Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 131.58 USD 1.04% Market Closed
Market Cap: $5.8B

Teleflex Inc
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Teleflex Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Total Equity
$3.1B
CAGR 3-Years
-8%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Total Equity
$24.2B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
14%
Edwards Lifesciences Corp
NYSE:EW
Total Equity
$10.3B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Total Equity
$22.4B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Equity
$52.1B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$17.8B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Teleflex Inc
Glance View

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
126.55 USD
Overvaluation 4%
Intrinsic Value
Price $131.58

See Also

What is Teleflex Inc's Total Equity?
Total Equity
3.1B USD

Based on the financial report for Dec 31, 2025, Teleflex Inc's Total Equity amounts to 3.1B USD.

What is Teleflex Inc's Total Equity growth rate?
Total Equity CAGR 10Y
5%

Over the last year, the Total Equity growth was -27%. The average annual Total Equity growth rates for Teleflex Inc have been -8% over the past three years , -1% over the past five years , and 5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett